Literature DB >> 3037844

Almitrine neuropathy. A nerve biopsy study of 8 cases.

R Gherardi, M Baudrimont, F Gray, F Louarn.   

Abstract

We report the quantitative and qualitative, light and electron microscopic studies, including teased fiber preparations of nerve biopsies obtained from eight patients, treated with almitrine, presenting with the characteristic association of a sensory peripheral neuropathy with a recent body weight loss. The data were consistent with an axonal damage affecting myelinated fibers, predominantly large ones and to a lesser degree unmyelinated fibers, some degree of segmental demyelination. Marked axonal regeneration was observed when the nerve biopsy was delayed after withdrawal of the drug, Micro-angiopathy secondary to the formation of concentric lamellae from the basement membrane was observed in five patients suffering from chronic hypoxemia. Almitrine is an agonist of the chemoreceptors. The pathogenesis of the toxic neuropathy induced by this compound remains obscure. Clinical features do not fit with a purely hypoxic mechanism at the origin of the neuropathy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037844     DOI: 10.1007/BF00693790

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Peripheral neuropathy during treatment with almitrine.

Authors:  F Chedru; R Nodzenski; J F Dunand; G Amarenco; R Ghnassia; C Ciaudo-Lacroix; G Said
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23

2.  Peripheral neuropathy in chronic disease of the respiratory tract.

Authors:  O Appenzeller; R D Parks; J MacGee
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

3.  [Peripheral axonic neuropathy during treatment with almitrine bismesylate (Vectarion). Possible role of wasting].

Authors:  R Gherardi; F Louarn; M Perrier; J F Eizenbaum
Journal:  J Toxicol Clin Exp       Date:  1985 Nov-Dec

4.  Almitrine and peripheral neuropathy.

Authors:  A J Suggett; J A Jarratt; A Proctor; P Howard
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

5.  Peripheral neuropathy in patients treated with almitrine dimesylate.

Authors:  R Gherardi; F Louarn; C Benvenuti; M Perrier; J L Lejonc; A Schaeffer; J D Degos
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

6.  A clinicopathologic study of acrodystrophic neuropathies.

Authors:  G Said
Journal:  Muscle Nerve       Date:  1980 Nov-Dec       Impact factor: 3.217

7.  [11 cases of neuropathy induced by almitrine, of which one had optic neuropathy].

Authors:  M Blondel; G Arnott; S Defoort; B Bouchez; P Persuy; M Masingue; J C Hache; I Krivosic
Journal:  Rev Neurol (Paris)       Date:  1986       Impact factor: 2.607

8.  [Incidence of polyneuropathies in chronic obstructive bronchopneumopathies].

Authors:  B Paramelle; A Vila; P Pollak; P Muller; D Gavelle; F Reymond; C Brambilla; P Stoebner
Journal:  Presse Med       Date:  1986-03-22       Impact factor: 1.228

9.  Peroneal muscular atrophy. Part 2. Nerve biopsy studies.

Authors:  R Gherardi; P Bouché; R Escourolle; J J Hauw
Journal:  J Neurol Sci       Date:  1983 Oct-Nov       Impact factor: 3.181

10.  Subclinical neuropathy associated with chronic obstructive pulmonary disease: possible pathophysiologic role of smoking.

Authors:  A Faden; E Mendoza; F Flynn
Journal:  Arch Neurol       Date:  1981-10
View more
  6 in total

1.  Almitrine-induced peripheral neuropathy and weight loss.

Authors:  R Gherardi; L Bélec; F Louarn
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

2.  Extensive oxidative metabolism of dextromethorphan in patients with almitrine neuropathy.

Authors:  L Belec; D Larrey; H De Cremoux; M Tinel; F Louarn; D Pessayre; R Gherardi
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

3.  Peripheral neuropathies during treatment with almitrine: report of 46 cases.

Authors:  P Bouche; L Lacomblez; J M Leger; M P Chaunu; H Ratinahirana; P Brunet; J J Hauw; H P Cathala; D Laplane
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

4.  Microangiopathy of endoneurial vessels in hypoxemic chronic obstructive pulmonary disease (COPD). A quantitative ultrastructural study.

Authors:  P Stoebner; P Mezin; A Vila; R Grosse; N Kopp; B Paramelle
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Lipidosis of the dorsal root ganglia in rats treated with an almitrine metabolite.

Authors:  Y Yamanaka; E Sakamoto; Y Sakuma; H Uno; T Koyama; Y Izawa; K Fujiwara
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

6.  Pharmacological interventions in acute respiratory distress syndrome.

Authors:  Antoine Roch; Sami Hraiech; Stéphanie Dizier; Laurent Papazian
Journal:  Ann Intensive Care       Date:  2013-07-03       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.